Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Intrexon Acquires Oxitec, Partners on Genetic Disorder

Diamondback moth (Olaf Leillinger, Wikimedia Commons)

10 August 2015. Intrexon Corp., a biotechnology company specializing in synthetic biology, is acquiring Oxitec Ltd., a designer of genetically modified insects to control the spread of disease-bearing and agricultural pests for $160 million. Intrexon is also partnering with Synthetic Biologics Inc. to develop therapies for phenylketonuria, . . . → Read More: Intrexon Acquires Oxitec, Partners on Genetic Disorder

Nicotine Destroying Drug Candidate Discovered

(Pakura, Pixabay)

7 August 2015. Biochemists at Scripps Research Institute reported on an enzyme derived from naturally-occurring bacteria that shows in lab tests can remove nicotine in the blood, with potential as a drug to help smokers quit. The team from the lab of chemistry professor Kim Janda at Scripps’s La Jolla, California . . . → Read More: Nicotine Destroying Drug Candidate Discovered

Peanut Allergy Therapy Company Raises $160 Million in IPO

(National Institute of Food and Agriculture, USDA)

6 August 2015. Aimmune Therapeutics Inc., a developer of treatments for peanut and other food allergies, raised $160 million from its initial public stock offering, pricing its 10 million shares at $16.00. Shares in the Brisbane, California company trade on the Nasdaq exchange under the symbol . . . → Read More: Peanut Allergy Therapy Company Raises $160 Million in IPO

Computer Model Provides Early Sepsis Alert

Suchi Saria, right, with first author Katherine Henry (Will Kirk, Homewood Photo, Johns Hopkins University)

6 August 2015. Researchers at Johns Hopkins University wrote a computer model that gives clinicians an early and accurate warning that a patient is developing sepsis, a life-threatening complication of infections. The team of medical researchers, computer scientists, . . . → Read More: Computer Model Provides Early Sepsis Alert

Pharma Licenses University Antibiotic Enhancements

(Centers for Disease Control and Prevention)

5 August 2015. Technologies that remove side-effect causing toxicity from gentamicin, a powerful antibiotic drug, are being licensed from two universities by La Jolla Pharmaceutical Company. Financial terms of the agreements between the San Diego biopharmaceutical developer and University of Alabama in Birmingham and University of Indiana . . . → Read More: Pharma Licenses University Antibiotic Enhancements

Gates Expands Collaboration with RNA Vaccine Maker

(FirstResponder.gov)

4 August 2015. CureVac, a designer of vaccines and therapies based on messenger RNA — genetic signals sent from DNA to a person’s cells — is expanding its partnership with the Bill and Melinda Gates Foundation to include a third viral disease affecting low-resource regions. Financial details of the new collaboration between . . . → Read More: Gates Expands Collaboration with RNA Vaccine Maker

Robotics Harnessed to Produce Adult Stem Cells

Induced pluripotent stem cells reprogrammed from human skin (California Institute for Regenerative Medicine)

4 August 2015. An automated system now uses robotics instead of manual lab handling to convert skin samples from individuals into stem cells that can transform into any other cells in the body, for regenerative medicine, drug development, and research. . . . → Read More: Robotics Harnessed to Produce Adult Stem Cells